Literature DB >> 19707788

Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Paul F Kantor1, Luc L Mertens.   

Abstract

Current evidence suggests that almost half of all children with cardiomyopathy and symptomatic heart failure will die or require a cardiac transplant within 5 years of diagnosis. The recognition, diagnostic assessment, and treatment of heart failure in children are therefore challenging undertakings, to say the least. It involves an assessment of cardiac appearance and function, adaptation of the child as a whole, and a diagnostic approach that evaluates many possible root causes. This review is intended to assist the practicing pediatrician and cardiologist by providing a framework for this diagnostic assessment and to give an overview of the treatment options available for children with heart failure. In this first part, we will focus on clinical evaluation, diagnostic testing, and initial medical management. In the second part of this series, the maintenance treatment and treatment options applicable when medical treatment is insufficient will be addressed.

Entities:  

Mesh:

Year:  2009        PMID: 19707788     DOI: 10.1007/s00431-009-1024-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  66 in total

1.  Treatment of congestive heart failure.

Authors:  Lynne Warner Stevenson
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

2.  Congestive heart failure.

Authors:  J D KEITH
Journal:  Pediatrics       Date:  1956-09       Impact factor: 7.124

Review 3.  Cardiac disease in Costello syndrome.

Authors:  E S Siwik; K G Zahka; G L Wiesner; C Limwongse
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

4.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

5.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  Cardiac findings in adolescents with anorexia nervosa at diagnosis and after weight restoration.

Authors:  José L Olivares; Margarita Vázquez; Jesús Fleta; Luis A Moreno; José M Pérez-González; Manuel Bueno
Journal:  Eur J Pediatr       Date:  2005-03-15       Impact factor: 3.183

7.  Cardiac and clinical phenotype in Barth syndrome.

Authors:  Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

8.  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.

Authors:  Simon Thackray; Joanne Easthaugh; Nick Freemantle; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

9.  Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy.

Authors:  Mark A Westwood; Farrukh Shah; Lisa J Anderson; Julian W Strange; Mark A Tanner; Alicia M Maceira; Jo Howard; John B Porter; J Malcolm Walker; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2007-09       Impact factor: 4.813

Review 10.  The utility of levosimendan in the treatment of heart failure.

Authors:  Lasse Lehtonen; Pentti Põder
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

View more
  3 in total

1.  Dyssynchronous ventricular activation in asymptomatic wolff-Parkinson-white syndrome: a risk factor for development of dilated cardiomyopathy.

Authors:  Floris Ea Udink Ten Cate; Nathalie Wiesner; Uwe Trieschmann; Markus Khalil; Narayanswami Sreeram
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

2.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

3.  Pediatric cardiac emergencies: Children are not small adults.

Authors:  Aisha Frazier; Elizabeth A Hunt; Kathryn Holmes
Journal:  J Emerg Trauma Shock       Date:  2011-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.